Highlights Myomo, Inc.

Equities

MYO

US62857J2015

Market Closed - Nyse Other stock markets 21:00:00 27/06/2024 BST			5-day change	1st Jan Change
3.02 ^USD	+0.67%		-3.82%	-39.72%

05-23	Lake Street Starts Myomo With Buy Rating, $7 Price Target	MT
05-08	Transcript : Myomo, Inc., Q1 2024 Earnings Call, May 08, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Myomo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	05-08	CI
Myomo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Myomo Receives Reimbursements For MyoPros from CMS	05-06	MT
Earnings Flash (MYO) MYOMO Reports Q4 Revenue $4.8M, vs. Street Est of $4.8M	03-07	MT
Myomo, Inc. Provides Earnings Guidance for the First Quarter of 2024	03-07	CI
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-07	CI
Myomo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-07	CI
Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023	01-17	CI
Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M	11-07	MT
Myomo, Inc. Provides Revenue Guidance for the Full Year of 2023	11-07	CI
Myomo, Inc. Announces CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro for Review at the Upcoming HCPCS Public Meeting	11-06	CI
Earnings Flash (MYO) MYOMO Posts Q2 Revenue $6M, vs. Street Est of $5.6M	09/08/23	MT
Myomo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
Centers for Medicare and Medicaid Services Accepts Myomo, Inc.'s Application to Classify the MyoPro as A Brace	03/07/23	CI
Earnings Flash (MYO) MYOMO Posts Q1 Revenue $3.45M, vs. Street Est of $3.34M	10/05/23	MT
Myomo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Myomo, Inc. Reiterates Revenue Guidance for the Second Quarter of 2023	10/05/23	CI
Myomo, Inc. Provides Revenue Guidance for the Second Quarter of 2023	10/05/23	CI
Myomo, Inc. Receives Technology License Fee Payment from China Joint Venture Company	10/04/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Myomo, Inc.

Equities

MYO

US62857J2015

Highlights

Filters